Oncology & Cancer

Novel agent reactivates an immune call by LIF blockade

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T cells to target and eliminate cancer. ...

Oncology & Cancer

A 'one-two punch' to wipe out cancerous ovarian cells

Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the ...

Genetics

Fetal genome involved in triggering premature birth

Mutations in the gene that codes for SLIT2, a protein expressed in fetal cells in placentas and involved in directing the growth of the fetal nervous system, may contribute to premature births, possibly by activating the ...

Diabetes

Drug delays type 1 diabetes in people at high risk

A treatment affecting the immune system effectively slowed the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded research. The study is the first ...

Diseases, Conditions, Syndromes

Sick with the flu? Here's why you feel so bad

"You never forget the flu." This is the title of the Victorian health department's current campaign, which highlights people's recollections of having the flu.

page 1 from 2